Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11/05/11 |
Kirk Look
DFI | Director of Finance/CFO | - | 01/04/03 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/20 |
Jon Patton
IRC | Investor Relations Contact | - | 01/08/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 07/09/22 |
Patricia Andrews
BRD | Director/Board Member | 66 | 09/01 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 08/06/15 |
James Parsons
BRD | Director/Board Member | 58 | 16/06/22 |
Angela Holtham
BRD | Director/Board Member | 73 | 18/06/14 |
Matthew Coffey
CEO | Chief Executive Officer | - | 11/05/11 |
Wayne Pisano
CHM | Chairman | 69 | 09/05/13 |
Deborah Brown
BRD | Director/Board Member | - | 02/11/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 75 419 768 | 72 478 872 ( 96,10 %) | 0 | 96,10 % |
Coordinate società
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+29,77% | 49,46 Mrd | |
+1,00% | 42,58 Mrd | |
+50,47% | 42,49 Mrd | |
-5,26% | 29,09 Mrd | |
+13,68% | 26,61 Mrd | |
-22,99% | 18,64 Mrd | |
+8,22% | 13,16 Mrd | |
+32,41% | 12,55 Mrd | |
-1,62% | 11,98 Mrd |